Skip to main content
Anna Ferrari, MD, Oncology, New Brunswick, NJ

Anna Ferrari MD


Professor, Medicine, New York University School of Medicine

Join to View Full Profile
  • 195 Little Albany StNew Brunswick, NJ 08901

  • Phone+1 732-235-7687

  • Fax+1 732-235-8808

Are you Dr. Ferrari?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Anna Ferrari, MD is an oncologist in New Brunswick, New Jersey. She is currently licensed to practice medicine in New Jersey and New York. She is a Professor at New York University School of Medicine.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1986 - 1987
  • Jacobi Medical Center/Albert Einstein College of Medicine
    Jacobi Medical Center/Albert Einstein College of MedicineFellowship, Hematology and Medical Oncology, 1985 - 1986
  • MedStar Health Georgetown University (Baltimore)
    MedStar Health Georgetown University (Baltimore)Residency, Internal Medicine, 1982 - 1985
  • Universidad de la República - Facultad de Medicina
    Universidad de la República - Facultad de MedicinaClass of 1974

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1985 - 2025
  • NJ State Medical License
    NJ State Medical License 2015 - 2019
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Madison Vaccines Incorporated Says Its Investigational New Prostate Cancer Treatment Is Available for the First Time in New Jersey Through a Clinical Trial at Rutgers Cancer Institute of New Jersey
    Madison Vaccines Incorporated Says Its Investigational New Prostate Cancer Treatment Is Available for the First Time in New Jersey Through a Clinical Trial at Rutgers Cancer Institute of New JerseyOctober 27th, 2016